Intellectual Property

EP2550298 B1, Richard S. Kornbluth and Geoffrey W. Stone, G.W. Self-Adjuvanting Vaccines Against Microbes and Tumors. Priority Date: May 23, 2010.
This issued European patent covers adjuvant uses of LMP1 and LMP1 fusion proteins and compositions-of-matter for LMP1-TNFRSF fusion proteins.

US20130039942 A1, Richard S. Kornbluth and Geoffrey W. Stone, G.W. Self-Adjuvanting Vaccines Against Microbes and Tumors. Priority Date: May 23, 2010.
This pending US application covers adjuvant uses of LMP1 and LMP1 fusion proteins and compositions-of-matter for LMP1-TNFRSF fusion proteins.

US 8,932,575 B2, Geoffrey W. Stone. Compositions and Methods for Inducing Migration by Dendritic Cells and an Immune Response. Priority Date Sept. 21, 2010.
This issued US patent covers the use of dendritic cells for cancer immunotherapy and vaccines. Receptome, LLC has an exclusive license to this patent from the University of Miami.

WO 2014/039961 A1. Geoffrey W. Stone and Sachin Gupta. Fusion Proteins for Promoting an Immune Response, Nucleic Acids Encoding Same, and Methods of Making and Use Thereof.
Priority Date: September 7, 2012.
This PCT patent application covers LMP1-IPS-1 STING pathway activator and other fusion proteins that activate immune cells. Receptome, LLC has an exclusive license to this patent from the University of Miami.